Search research articles
Contact Us
Filters
Showing results (21-30 of 65) with videos related to
Page
of 7
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2006
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
Sophia Koukouraki, Ludwig G Strauss, Vassilios Georgoulias, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
February 8, 2003
Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer
Trias Thireou, Ludwig G Strauss, Antonia Dimitrakopoulou-Strauss, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 13, 2009
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
Ludwig G Strauss, Johannes Hoffend, Dirk Koczan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 16, 2007
Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
Ludwig G Strauss, Sven Klippel, Leyun Pan, et al.
Clinical Nuclear Medicine
|
August 18, 2012
Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model
Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, Leyun Pan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
October 23, 2013
Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
Betül Celik, Arzu Didem Yalcin, Atil Bisgin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2007
68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG
Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, Uwe Haberkorn, et al.
Biomed Research International
|
June 14, 2013
Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib
Bernd Kasper, Antonia Dimitrakopoulou-Strauss, Lothar R Pilz, et al.
Clinical Nuclear Medicine
|
January 12, 2011
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results
Antonia Dimitrakopoulou-Strauss, Marcel Seiz, Jochen Tuettenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2004
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
Antonia Dimitrakopoulou-Strauss, Ludwig G Strauss, Cyrill Burger, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 65) with videos related to
Sort By:
Page
of 7
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2006
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
Sophia Koukouraki, Ludwig G Strauss, Vassilios Georgoulias, et al.
Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society
|
February 8, 2003
Performance evaluation of principal component analysis in dynamic FDG-PET studies of recurrent colorectal cancer
Trias Thireou, Ludwig G Strauss, Antonia Dimitrakopoulou-Strauss, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 13, 2009
Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics
Ludwig G Strauss, Johannes Hoffend, Dirk Koczan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 16, 2007
Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?
Ludwig G Strauss, Sven Klippel, Leyun Pan, et al.
Clinical Nuclear Medicine
|
August 18, 2012
Dynamic PET with FDG in patients with unresectable aggressive fibromatosis: regression-based parametric images and correlation to the FDG kinetics based on a 2-tissue compartment model
Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, Leyun Pan, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
October 23, 2013
Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers
Betül Celik, Arzu Didem Yalcin, Atil Bisgin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 17, 2007
68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG
Antonia Dimitrakopoulou-Strauss, Peter Hohenberger, Uwe Haberkorn, et al.
Biomed Research International
|
June 14, 2013
Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib
Bernd Kasper, Antonia Dimitrakopoulou-Strauss, Lothar R Pilz, et al.
Clinical Nuclear Medicine
|
January 12, 2011
Pharmacokinetic studies of ⁶⁸Ga-labeled Bombesin (⁶⁸Ga-BZH₃) and F-18 FDG PET in patients with recurrent gliomas and comparison to grading: preliminary results
Antonia Dimitrakopoulou-Strauss, Marcel Seiz, Jochen Tuettenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 7, 2004
Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy
Antonia Dimitrakopoulou-Strauss, Ludwig G Strauss, Cyrill Burger, et al.
Page
of 7